Fri, Sep 19, 2014, 11:16 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Puma Biotechnology, Inc. Message Board

  • miamigent1 miamigent1 Dec 7, 2013 3:04 AM Flag

    Started PBYI Short Friday

    (reprint)

    PBYI Evening, Lee!

    Yes, I did that as part of my pre-flight check list and it does look like it could add a few dollars but I started a short anyway- at 79.94, a little early it turns out. I enter in up to three stages and that was stage one.
    I think it is being goosed along more than the news warrants, aided by the OS that is tightly held.
    Trial 2 results for efficacy only were apparently favorable but it's no slam dunk and a long way to possible approval. This cancer drug candidate, "Neratinib" was licensed to PUMA by after Pfizer's own Trial 2 of elicited terrible side effects- worse than chemo.
    Conceivably a winner in the long run but with bios the odds are always against that.
    Anyway, 88% in two days seems stretched, and an RSI at 86 says overbought.
    My second short of PBYI was 35 pts from filling today.
    As with any short, it is best to go lightly.
    Helping out at my church all weekend- I better get to dreamland!
    Have a good weekend, Lee and all!

    MG

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PBYI
270.32-4.75(-1.73%)Sep 19 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TC PipeLines, LP
NYSEFri, Sep 19, 2014 4:00 PM EDT